Company news
Bioxyne Limited (ASX:BXN) news
Bioxyne Limited news releases on 6ix. Latest, Nov 4, 2021: Bioxyne Not to Proceed with Proposed Acquisition
Press releases — page 2
Bioxyne Not to Proceed with Proposed Acquisition
November 3, 2021
Suspension from Quotation
October 28, 2021
Explanatory Note to the 2021 Annual Report
September 30, 2021
Appendix 4C - quarterly
April 30, 2021
Appendix 4D and Half Year Accounts
February 25, 2021
Appendix 4C - Quarterly December 2020
January 28, 2021
Market Update
April 13, 2020
Quarterly Activities Report
October 28, 2018
Bioxyne Expands to Indonesia with Acquisition
September 24, 2018
Quarterly Activities and Quarterly Cash Flow Report
July 27, 2018
Bioxyne to Distribute GRAYNS Starch Reducing Rice Cooker
June 11, 2018
Expands to Thailand, Philippines, Myanmar, Cambodia,
May 20, 2018
Quarterly Activities and Quarterly Cash Flow Reports
April 27, 2018
Appendix 4D and Interim Financial Report
February 28, 2018
Unique NZ Colostrum Honey Dairy Product for China and S.E.A
February 25, 2018
Quarterly Activities and Quarterly Cash Flow Report Dec 17
January 30, 2018
Additional New Products Launched for Direct Sales
January 15, 2018
Positive Bioxyne Gut Health Clinical Trial Results
December 11, 2017
Bioxyne Launches NZ Dairy Formula Product in South East Asia
December 6, 2017
Quarterly Activities Report and Appendix 4C
October 25, 2017
Malaysian Direct Selling Licence to Propel Bioxyne into MLM
October 24, 2017
Response to ASX Price Query Letter
October 15, 2017
Appendix 4E Preliminary Final Report
August 31, 2017
Quarterly Activities Appendix 4C
July 31, 2017
Rights Issue - Notification of Shortfall
May 26, 2017
Prospectus - Rights Issue
May 3, 2017
Quarterly Activities and Cash Flow Report March 2017
April 27, 2017
Acquires NZ Product Company for Direct Sales Asia Pacific
April 19, 2017
Appendix 4D and Half Year Report
February 27, 2017
Bioxyne to Access Chinese Market for Online Sales via JD.com
February 20, 2017
Quarterly Activities and Cash Flow Report Dec 2016
January 24, 2017
Launch of Two Products Containing PCC Onto Australian Market
November 1, 2016
Appendix 4E - Preliminary Final Report
August 30, 2016
Appendix 4C - June Quarterly
July 28, 2016
Bioxyne Commences New Clinical Trial
June 23, 2016
Appendix 4C - March quarterly
April 25, 2016
Update On Commercialisation Process
March 30, 2016
Appendix 4D - Half Yearly Report and Accounts
February 26, 2016
Appendix 4C - December Quarterly
February 11, 2016
Mariposa Health Inc. Investment Update
February 10, 2016
Bioxyne Ltd : Amended Appendix 3Y’s for Adjustment to Directors Share Interests
February 11, 2014
Bioxyne Ltd : December 2013 Quarterly update and Appendix 4C
February 11, 2014
Bioxyne Ltd : Expiry of Unquoted Options
December 4, 2013
Bioxyne Ltd : Sale of HI-164OV Hunter Immunology Pty Ltd
December 2, 2013
Bioxyne Ltd : Appendix 4C - September Quarterly
October 31, 2013
Bioxyne Ltd : Confirmation of Release - BXN - Termination of proposed acquisition - Vitality Devices
May 23, 2013
Bioxyne Ltd : Confirmation of Release - BXN - Appendix 4C - quarterly - 31 March 2013
April 30, 2013
Bioxyne Ltd : Confirmation of Release - BXN - Vitality Devices Acquisition Update
March 4, 2013
Bioxyne Ltd : Confirmation of Release - BXN - Completion of placement follow up
February 20, 2013
Bioxyne Ltd : Confirmation of Release - BXN - Suspension Request
February 20, 2013